Valo Therapeutics
ID: 17662535Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.
4
Funding Rounds
$46.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Sa** Pe***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Valo Therapeutics has raised a total of $46.7m in funding over 4 rounds.
Key Insights:
- Valo Therapeutics Series A Round, March 2025: $20m
- Valo Therapeutics , November 2021: $12.5m
- Valo Therapeutics November 2021 Funding Round: $13m
- Valo Therapeutics , February 2020: $1.2m
Industries
Valo Therapeutics is active in the following industries: